Knee injection for osteoarthritis pain
Part of Bones, joints & muscles, Pain clinical trials.
This study tests an investigational treatment called StroMel, which is a single injection into the knee joint for people with moderate to severe knee osteoarthritis. The goal is to see if it is safe and helps reduce pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 25 and 65 years old.
- Your body mass index (BMI) must be less than 40.
- You need to have moderate to severe knee osteoarthritis, confirmed by X-ray within the last 6 months.
- You must have significant knee pain (scored at least 11 out of 20 on a standard pain questionnaire and at least 40 out of 100 on a pain scale).
- You must have tried at least two other treatments for your knee pain (like pain relievers, physical therapy, or weight loss) for at least 6 months without enough relief.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This study tests a single injection into the knee joint to see if it relieves pain from knee osteoarthritis. It may help people who have tried other treatments without feeling better.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.
This study tests a new injection for knee osteoarthritis that aims to improve pain and function. It may help if you have moderate to severe knee pain that hasn't been relieved by first-line treatments.
Hear when a new Osteo Arthritis Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.